Hematology Prof. Dr. Mustafa Çetiner
✓ Medically verified profile Hematology
Prof. Dr. Mustafa Çetiner
✓ Medically verified profile 37+ years experienceLanguages: Turkish, EnglishOnline consultationAcibadem Maslak Hospital · İstanbul
★★★★★ From 2,400+ verified Acibadem patient reviews
Profile
About Prof. Dr. Mustafa Çetiner
Quick answer
Prof. Dr. Mustafa Çetiner is a Hematology specialist at Acibadem Maslak Hospital in İstanbul with 37+ years of experience.
He treats blood disorders and hematologic cancers including chronic immune thrombocytopenia, thrombotic thrombocytopenic purpura, myelodysplastic syndromes, acute myeloid leukemia, lymphomas, multiple myeloma, POEMS syndrome, iron deficiency anemia, and febrile neutropenia, and performs hematopoietic stem cell transplantation, bone marrow transplantation, and therapeutic apheresis. He consults in Turkish and English and offers online video consultations.
Prof. Mustafa Çetiner is a hematologist with a medical degree from Marmara University Faculty of Medicine (2000). He brings extensive clinical and academic experience, currently affiliated with Acibadem Health Group since 2019. His work focuses on hematology, stem cell and regenerative medicine, and related areas of internal medicine. He is active in national and international professional communities, holding memberships in the Turkish Medical Association, Turkish Hematology Association, Turkish Internal Medicine Specialty Society, Turkish Immunology Association, Turkish Society of Thrombosis and Hemostasis, and the University Faculty Members Association.
Internationally, he is a member of the European Hematology Association, American Society of Hematology, European Bone Marrow Transplantation Registry, and the MDS Foundation. He also supports patient advocacy through the Cancer Fighters Association and contributes to developments in stem cell research via the Stem Cell and Regenerative Medicine Association. Colleagues and patients know him for combining evidence-based care with a patient-centered approach, and for his commitment to collaboration across clinical and research teams.
Clinical Focus
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Chronic immune thrombocytopeniaThrombotic thrombocytopenic purpuraMyelodysplastic syndromesAcute myeloid leukemiaDiffuse large B-cell lymphomaBurkitt lymphomaHodgkin lymphomaMultiple myelomaPOEMS syndromeIron deficiency anemiaFebrile neutropeniaHematopoietic stem cell transplantationBone marrow transplantationTherapeutic apheresis
Background
Education
- 2000Marmara University Faculty of Medicine Hematology
- 1994Karadeniz Technical University Faculty of Medicine Internal Medicine
- 1988Ankara University Faculty of Medicine
Career
Professional Experience
- 2019Acibadem Health Group
- 2016–2019Head of Department of Internal Medicine, Koç University School of Medicine
- 2016–2019Founder and Chairman of the Department of Internal Medicine, Koç University School of Medicine
- 2013–2019Koç University School of Medicine Internal Medicine Coordinator
- 2013Koç University School of Medicine / Professor
- 2011–2012Founder and Director of Şişli Memorial Hospital Bone Marrow Transplant Unit / Associate Professor
- 2010–2013Şişli Memorial Hospital Bone Marrow Transplant Unit Director
- 2010WHO (World Health Organization) and UN (United Nations) Physician
- 2008–2017American Hospital Therapeutic Apheresis Responsible Physician
- 2008V.K.V. American Hospital Department of Hematology / Associate Professor
- 2006–2008Marmara University / Internal Medicine / Hematology / Associate Professor
- 2004–2005Hematopetic Stem Cell Transplantation Program / Department of Medicine / Feinberg School of Medicine / Northwestern University / Guest Lecturer
- 2001–2006Marmara University / Internal Medicine / Hematology / Assistant Assoc.
- 1998–2001Marmara University / Internal Medicine / Hematology / Specialist Dr.
- 1997–2000Marmara University Faculty of Medicine / Internal Medicine / Hematology / Dr.Ar.Assist.
- 1994–1997Ministry of National Education Beşevler Health Education Center / Specialist Dr.
- 1989–1994Internal Medicine Faculty of Medicine Karadeniz Technical University / Dr.Ar.Assist.
Affiliations
Professional Memberships
- Turkish Medical Association
- Cancer Fighters Association
- European Hematology Association
- American Society of Hematology
- European Bone Marrow Transplantation Registry
- Turkish Internal Medicine Specialty Society
- Turkish Hematology Association
- MDS Foundation
- Turkish Immunology Association
- University Faculty Members Association
- Stem Cell and Regenerative Medicine Association
- Turkish Society of Thrombosis and Hemostasis
Research
Selected Publications
- A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia Turk J Haematol. 2019 Jul 22. doi: 10.4274/tjh.galenos.2019.2018.0307. Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, Haydaroglu Sahin H, Ermis Turak E, Esen R, Comert M, Sadri S, Aslaner M,
- The role of atopy in the pathogenesis of bleomycin pulmonary toxicity Respiratory Medicine. (2019) Ozyigit, L. P., Aktas, E. C., Senbas, Z. A., Ozturk, A. B., Ozturk, E., Ergonul, M. Tabak L, Ferhanoglu B, Cetiner M, Deniz G.
- Rituximab desensitization in three patients with severe rituximab allergy. Curr Probl Cancer. 2017 Sep- Oct;41(5): 349-354 Öztürk E, Özyiğit LP, Öztürk AB, Akay MO, Çetiner M, Ferhanoğlu B.
- Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma Leuk Lymphoma. 2017 May;58(5):1114-1122 Falay O, Öztürk E, Bölükbaşı Y, Gümüş T, Örnek S, Özbalak M, Çetiner M, Demirkol O, Ferhanoğlu B.
- Implementation of an antimicrobial stewardship program for patients with febrile neutropenia Am J Infect Control. 2017 Nov 22. pii: S0196-6553(17) 31136-7. doi: 10.1016/j.ajic.2017.09.030. [Epub ahead of print] Madran B, Keske Ş, Tokça G, Dönmez E, Ferhanoğlu B, Çetiner M, Mandel NM, Ergönül Ö
- Iron deficiency and anemia in heart failure Turk Kardiyol Dern Ars. 2017 Mar;45(Suppl 2):1-38 Cavusoglu Y, Altay H, Cetiner M, Guvenc TS, Temizhan A, Ural D, Yesilbursa D, Yildirim N, Yilmaz MB.
- Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Akpinar H, Cetiner M, Keshav S, Örmeci N, Törüner M.
- Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):178-80 Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Cetiner M, Ferhanoglu B, Sargin D.
- Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Leuk Lymphoma. 2016 May;57(5):1211-4. Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş,
- Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease. Blood Purif. 2016 Jun 18;42(2):160-167. Solak Y, Cetiner M, Siriopol D, Tarim K, Afsar B, Covic A, Kanbay M.
- GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro Hum Reprod. 2015 Dec;30(12):2912-25. Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B,
- Diagnostic contribution of (18) F-FDG-PET/CT in fever of unknown origin Int J Infect Dis. 2014; 19; 53-8 Tokmak H, Ergönul O, Demirkol O, Cetiner M, Ferhanoglu B
- Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and Hematuria Case Rep Urol. 2013 2013;2013:861232. doi: 10.1155/2013/861232. Epub 2013 Aug 19. Acar O, Esen T, Tecimer T, Cetiner M, Peker O, Musaoglu A
- Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in relapse setting: two case reports and a review of literature Transfusion. 2013 53 (7): 1586-93 Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B.
- Azacitidine has limited activity in “real life” patients with MDS and AML: a single centre experience Hematol Oncol 2011; 29: 1?6 Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B.
- Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid J Bone Miner Metab. 2009;27(4):435-43 Cetiner S, Sucak GT, Kahraman SA, Akı SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R.
- Bortezomib: A New Therapeutic Option for POEMS Syndrome Eur J Haematol. 2009 Sep 3. 84(2):175-7 Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M.
- L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death Cell Biol Toxicol 22 (1), 47-60, 2006 Şener, G., Eksioglu-Demiralp, E., Cetiner, M., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BC
- Beta-Glucan amoliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects Eur J Pharmacol. 2006 Aug 7;542(1-3):170-8 Sener G, Eksioglu-Demiralp, E, Cetiner M, Ercan F, Yeggen BC.
- Tar.ine protects against methotrexate-induced toxicity and inhibits leucocyte death Toxicology and Applied Pharmacology 209 (1), 39-50 (2005) Cetiner, M., Şener, G., Şehirli, Ö., Eksioglu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Akpolat, S., Tecimer, T., Yeğen, BC
- Non-B, non-T Neoplasms with Lymphoblast Morphology: Further Clarification and Classification Am J Surg Pathol, 28, 835-837 (2004). Ozdemirli, M., Cetiner, M
- Hairy Cell Leukemia in Father and Son Med Oncol, 20, 375-378 (2003). Cetiner, M., Adıgüzel, C., Argon, D., Ratip, S., Ekşioğlu-Demiralp, E., Tecimer, T., Bayık, M.
- Effect of Interferon-alpha-2a on Neutrophil Adhesion and Phagocytosis in Chronic Myeloid Leukemia and Behcet’s Disease Clin Rheumatol, 21, 211-214 (2002). Kart, S., Ovali, E., Ratip, S., Cetiner, M., Direskeneli, H., Bayık, M., Akoğlu, T
- COMPARISON OF TWO CRYOPRESERVATION METHODS ACCORDING TO STEM CELL VIABILITY AND COLONY FORMING CAPACITY International Journal of Hematology and Oncology, 28(4), 171-177. KARTI, S. S., ADIGÜZEL, C., YILMAZ, M., ÇETİNER, M., RATİP, S., EKŞİOĞLU, E., … & BAYIK, M.
- Clinical Microbiological Case: Chronic Disseminated Candidiasis Clinical Microbiology and Infection, 8, 435-436 (2002). Ratip, S., Odabaşı, Z., Kartı, S., Cetiner, M., Yeğen, C., Çerikçioğlu, N., Bayık, M., Korten, V
- Effectivness of FLAG chemotheraphy in refractory or relapsed acute myeloid leukemia Turk. J. Haematol, 18, 53-58.(2001) Ratip, S., Eryüksel, E., Odabaşı, Z., Çetiner, M., Özen, Y., Ovalı, E., … & Bayık, M.
- Normal Pressure Hydrocephalus Associated with Chronic Alpha Interferon Treatment: A Case Report Turk J Haematol, 17(1), 33-35.(2000) Ratip, S., Budak-Alpdoğan, T., Alpdoğan, Ö., Çetiner, M., Karti, S., ELMACI, İ., & Bayik, M.
- Effects of Omeprazole on Gallbladder Contraction in Humans Hepatogastroenterology, 47, 346-348 (2000). Kapıcıoğlu, S., Baki, A., Arslan, M., Cetiner, M., Cihanyurdu, N.
- Effects of angiotensin converting enzyme inhibitors in healthy rats and in rats with carbon tetrachloride-induced toxic hepatitis Turkish Journal of Medical Sciences, 30(4), 321-326.(2000) OVALI, E., ÇETİNER, M., RATİP, S., AYDIN, F., TEKELİOĞLU, Y., KARTI, S., … & AĞAOĞLU, N.
- Role of Hepatocyte Growth Factor in the Development of Dendritic Cells from CD 34+ Bone Marrow Cells Haematologica, 85, 464-469 (2000). Ovali, E., Ratip, S., Kibaroglu, A., Tekelioglu, Y., Cetiner, M., Karti, S., Aydin, F., Bayik, M., Akoglu, T.
- Measurement of unconjugated hyperbilirubinemia in Gilbert’s syndrome during compulsory fasting Marmara Medical Journal, 12(4), 171-174.(1999) Kapıcıoğlu, S., Çetiner, M., & Baki, A.
- Action of Buffered Aspirin (Alka-Seltzer)”on Gastric Mucosal Injury in Humans Annals of Medical Sciences, 8, 48-51.(1999) Kapicioglu, S., Cetiner, M., & Arslan, M.
- Bone marrow transplantation data for marmara university school of medicine: 1989-1998 Marmara Medical Journal, 11(4), 204-209.(1998) Çetiner, M., Ratip, S., Ovalı, E., Kartı, S., Bayık, M., & Akoğlu, T.
- The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompensated cirrhosis and healthy volunteers Turk J Gastroeruerol, 7, 22-26.(1996) CETINER, M., OVALI, E., YIGITER, Y., & KAPICIOGLU, S.
Good to Know
Frequently Asked Questions
What is Dr. Mustafa Çetiner's specialty?
Dr. Mustafa Çetiner is a specialist in Hematology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Mustafa Çetiner practise at?
Dr. Mustafa Çetiner sees patients at Acibadem Maslak Hospital in İstanbul. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Mustafa Çetiner?
Consultations with Dr. Mustafa Çetiner are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Mustafa Çetiner?
You can request an appointment with Dr. Mustafa Çetiner using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Mustafa Çetiner?
Yes. Dr. Mustafa Çetiner offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Mustafa Çetiner have?
Dr. Mustafa Çetiner has around 37 years of professional experience in Hematology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Mustafa Çetiner?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Mustafa Çetiner?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Book an Appointment
Schedule your appointment with Prof. Dr. Mustafa Çetiner
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
35+Years of expertise
90+Countries served
20+Languages spoken
24/7Patient support
Prefer to talk now?
Appointment Request
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Where
Hospitals
Departments
Medical Units
Treatments